913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
- Author
- Pharmacy Joe
- Published
- Mon 15 Apr 2024
- Episode Link
- https://pharmacyjoe.com/podcast/the-elective-rotation-podcast/913-is-there-an-efficacy-tradeoff-when-reducing-apixaban-dose-in-patients-with-end-stage-renal-disease/
Show notes at pharmacyjoe.com/episode913.
In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.
The post 913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease? appeared first on Pharmacy Joe.
